Cannabis finance news

Cannabiz Awards 2024 launch with new categories, new judges and two-stage judging process

by cannabiz team February 7, 2024February 9, 2024

The Cannabiz Awards for Australia and New Zealand 2024 launch today, with three new categories and […]

Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue

by Steve Jones February 7, 2024February 7, 2024

Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience

by Steve Jones and Martin Lane February 7, 2024November 25, 2024

Clarity over German legal scheme paves way for AusCann-Eurocann deal

by Steve Jones February 7, 2024February 7, 2024

Cannabis seeing ‘explosive growth’ but data reveals sales dogfight beyond the market leaders

by Steve Jones February 1, 2024February 1, 2024

Cann Group delivers ‘modest’ growth as imports continue to frustrate

by Steve Jones February 1, 2024February 1, 2024

‘Significant’ probe underway as Epsilon creditors raise ‘various matters’

by Steve Jones January 31, 2024July 11, 2024

LGP reports sales downturn but predicts a ‘re-rating’ of Australian firms amid US rescheduling report

by Steve Jones January 31, 2024July 11, 2024

Shareholders reject remuneration report as Althea is dealt ‘first strike’

by Steve Jones January 31, 2024July 11, 2024

Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix

by Steve Jones and Martin Lane January 31, 2024July 11, 2024